Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BalchemFRA:BL9B -0.43%94 12-1 Month Momentum % is 19.10% as of Sep. 21, 2026. GuruFocus rates FRA:BL9B with a GF Score™ of 94/100 and a GF Value™ of €156.72 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 1,613 Chemicals companies, Balchem ranks better than 65.16% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-09-21), Balchem's 12-1 Month Momentum % is 19.10%.
The industry rank for Balchem's 12-1 Month Momentum % or its related term are showing as below:
FRA:BL9B's 12-1 Month Momentum % is ranked better than 65.16% of 1613
companies
in the Chemicals industry
Industry Median: 0.41
vs FRA:BL9B: 19.10
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Balchem 12-1 Month Momentum % Related Terms
FRA:BL9B vs SXT, PRM, CBT: 12-1 Month Momentum % Comparison
For the Specialty Chemicals subindustry, Balchem's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Balchem 12-1 Month Momentum % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Balchem's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Balchem's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Balchem (FRA:BL9B) has a 12-1 Month Momentum % of 19.10% as of Sep. 21, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Balchem and its competitors. According to the industry distribution chart, Balchem ranks #562 out of 1613 companies in the Chemicals industry, placing it in the top 34.8%.
Is Balchem's 12-1 Month Momentum % too high?
Balchem's current 12-1 Month Momentum % is 19.10%. The Chemicals industry median 12-1 Month Momentum % is 0.41. Balchem's value of 19.10% is 4558.5% above this industry median. Based on the distribution chart, Balchem ranks #562 out of 1613 companies in the Chemicals industry, which is above the industry midpoint. Overall, Balchem has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Balchem's 12-1 Month Momentum % compare to SXT and PRM?
According to the Chemicals industry distribution chart, Balchem ranks #562 out of 1613 companies for 12-1 Month Momentum %. This puts Balchem in the upper half of its industry. The industry median 12-1 Month Momentum % is 0.41. Balchem's value of 19.10% is 4558.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Chemicals company?
The median 12-1 Month Momentum % among Chemicals companies is 0.41, based on 1,613 companies in the industry. Companies in the top quartile (top 25%) have a 12-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Balchem's current 12-1 Month Momentum % of 19.10% is 4558.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Balchem and its competitors. For the Chemicals industry, the median 12-1 Month Momentum % is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Balchem's current 12-1 Month Momentum % is 19.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Balchem stock overvalued right now?
Based on GuruFocus' analysis, Balchem (FRA:BL9B) is currently considered Modestly Undervalued. The stock's GF Value™ is €156.72, compared to a current price of €139.10 — trading 11.2% below its estimated fair value. The current 12-1 Month Momentum % is 19.10% and 4558.5% above the Chemicals industry median of 0.41. Balchem's overall GF Score™ is 94/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Balchem (FRA:BL9B), the current 12-1 Month Momentum % is 19.10% as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Balchem (FRA:BL9B) Overvalued in 2026?
Based on GuruFocus' analysis, Balchem stock appears to be undervalued.
The current stock price of €139.10 is trading 11.2% below its estimated GF Value™ of €156.72.
GuruFocus considers Balchem to be Modestly Undervalued.
Key valuation signals for FRA:BL9B:
12-1 Month Momentum %: 19.10%
GF Value™: €156.72 vs. price of €139.10 (11.2% below fair value)
Industry Position: 4558.5% above the Chemicals median (#562 of 1613)
No single metric tells the full story. See the FRA:BL9B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
94GF Score
Get the complete analysis for FRA:BL9B
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:BL9B has been successfully added to your 
